Kate Hunter-Salas


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.


Kate Hunter concentrates her practice on investigations and litigation related to inquiries involving alleged violations of the False Claims Act (FCA), the Foreign Corrupt Practices Act (FCPA), various securities laws and other federal statutes. She represents healthcare companies in responding to government investigations concerning issues of alleged healthcare fraud and abuse. She regularly counsels clients on compliance with the FCA and defends clients related to various state and federal agency investigations.

In addition, Kate helps clients stay up-to-date on regulatory developments related to corporate compliance matters and assists clients in conducting internal investigations and preparing and implementing anti-corruption compliance programs.

Prior to joining Bass, Berry & Sims, Kate was an associate in the Washington, D.C. office of Norton Rose Fulbright. Kate earned her law degree and an LL.M. in international and comparative law from Duke University School of Law. She earned a B.A. in international relations and economics from Tufts University.


American Health Lawyers Association (AHLA)